Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients
about
Modern brain tumor imagingImaging tumor metabolism using in vivo magnetic resonance spectroscopyImpacts of MR spectroscopic imaging on glioma patient management.Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.Magnetic Resonance (MR) Metabolic Imaging in Glioma.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.In vivo intervertebral disc characterization using magnetic resonance spectroscopy and T1ρ imaging: association with discography and Oswestry Disability Index and Short Form-36 Health SurveyRepeatability of edited lactate and other metabolites in astrocytoma at 3T.Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivoReduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imagingA rapid inversion technique for the measurement of longitudinal relaxation times of brain metabolites: application to lactate in high-grade gliomas at 3 T.Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.Magnetic resonance analysis of malignant transformation in recurrent glioma.Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing TumorComparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas.
P2860
Q27002344-CEB18133-C7A1-4C6D-B6F2-519085439347Q27002499-9258220D-9263-42E3-A04C-88C8DD754705Q30777660-633218CF-BB31-4684-95F6-E2B26505E4EAQ30914754-C5DDC768-A26D-4D6D-803D-E76E55457076Q31015256-3CF00ABC-D98D-4D72-8AD6-C004DA6685BCQ33888366-733D3747-2F64-4209-843F-193C8688F2A2Q33940463-6AD54A2C-1BED-48FB-8240-C03333A4DB0BQ34246635-F4C206E9-C0B4-4FC8-91D4-AD4CDA52315AQ34480495-1FEDE4A9-2546-4534-BC39-53617297ED2DQ34861608-F30947C8-9BD9-47E4-8B81-3BBDB8E88A7AQ35760631-C8CAE497-CD13-416D-8AC2-647339709893Q36603161-03182A96-9D99-4815-B79B-A53713DA8BC4Q36792743-83910D5F-1F8D-47D1-9630-46C90B86EB2AQ37168287-A6CEDF6A-C90A-4F8D-99D0-F06130594FB7Q37348479-5C024FD1-3C07-4DBF-996D-EBDA9B93A031Q37697784-AE9DAAE9-B39F-4D66-BCE3-0612B3DBB925Q38085889-14C3ADCC-99B6-430C-96F6-A297185BADB1Q38838109-FBA1B956-9F65-4B65-BDA8-43225D7A7F27Q38998271-EA091B0F-818A-402D-94FA-430A0FF1FFF2Q39439133-1A384600-F4FA-4580-9A84-6A9E28717E06Q39971986-A3A0AB3C-4464-40D6-B6AD-0D3A972832E2Q40281311-60A6594D-A057-4D46-881B-A24E1CC2370DQ42363638-501DA58E-4B18-4FC5-879F-98317025B728Q46664688-6B37E26B-004D-446E-8C55-6E6B083C48CEQ55690590-7E9E4752-4691-44E0-AE50-49EFEA90F715
P2860
Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Implementation of 3 T lactate- ...... r readout for gliomas patients
@ast
Implementation of 3 T lactate- ...... r readout for gliomas patients
@en
Implementation of 3 T lactate- ...... r readout for gliomas patients
@nl
type
label
Implementation of 3 T lactate- ...... r readout for gliomas patients
@ast
Implementation of 3 T lactate- ...... r readout for gliomas patients
@en
Implementation of 3 T lactate- ...... r readout for gliomas patients
@nl
prefLabel
Implementation of 3 T lactate- ...... r readout for gliomas patients
@ast
Implementation of 3 T lactate- ...... r readout for gliomas patients
@en
Implementation of 3 T lactate- ...... r readout for gliomas patients
@nl
P2093
P2860
P1476
Implementation of 3 T lactate- ...... r readout for gliomas patients
@en
P2093
Albert P Chen
Daniel B Vigneron
Ilwoo Park
Matthew L Zierhut
Sarah J Nelson
P2860
P2888
P304
P356
10.1007/S10439-010-0128-X
P577
2010-07-23T00:00:00Z
P5875
P6179
1015862575